ACC 2014 Roundup: Study shows long-term benefits for some CRT-D patients
Seven-year results from Boston Scientific's MADIT-CRT trial show long-term benefits for some patients with mild heart failure.
Some patients with mild heart failure show significant, long-term benefits from cardiac-resynchronization therapy, according to the 7-year results from Boston Scientific's (NYSE:BSX) MADIT-CRT clinical trial presented at the American College of Cardiology's annual meeting over the weekend.
American College of Cardiology, Boston Scientific, Abbott LaboratoriesNews Well, Clinical Trials, ACC 2014, Bariatrics, Diabetes, Replacement Heart Valves, Stent Warsread more
Source: Mass Device - Category: Medical Equipment Authors: Brad Perriello Source Type: news
More News: Cardiac Resynchronization Therapy | Cardiology | Clinical Trials | Diabetes | Endocrinology | Heart | Heart Failure | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Medical Devices | Study